Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?

Bear, Adham S

Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements? [electronic resource] - Molecular therapy : the journal of the American Society of Gene Therapy Feb 2012 - 246-9 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1525-0024

10.1038/mt.2011.288 doi


Animals
Cell Line
Clinical Trials as Topic
Genetic Therapy--adverse effects
Genetic Vectors--genetics
Humans
Retroviridae--genetics
T-Lymphocytes--metabolism
Toxicity Tests--economics
Transduction, Genetic
Virus Replication--genetics